Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma.
靶向治疗与表观遗传治疗相结合,通过稳定胰腺导管腺癌中 GATA6 依赖的 MHCI 表达来增强抗肿瘤免疫力。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-69013-y
Peng JuanFei, Yang JiaJin, Antonopoulou Georgia, Fang Rui, Adhikari Bikash, Vogt Markus, Wolf Elmar, Sun Chong, Du Shangce, Godfrey Laura, Gupta Aayush, Trajkovic-Arsic Marija, Teichmann Nicole, Grünwald Barbara T, Krebs Niklas, Steiger Katja, Mogler Carolin, Althoff Kristina, Wang Xin, Giglio Giovanni, Liffers Sven-Thorsten, Savvatakis Konstantinos, Braren Rickmer, Lawlor Rita T, Scarpa Aldo, Behrens Diana, Lang Karl S, Cheung Phyllis F, Siveke Jens T